Okuda Y

No ORCID on file · 5 papers in corpus · active 2009-2026

Study types

  • article 2
  • other 1

Condition tags

  • adenomyosis 2
2026
Frontiers in medicine ·doi:10.3389/fmed.2026.1704529

BackgroundRelugolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, represents a potentially effective and less invasive therapeutic approach for retained products of conception (RPOC). However, its impact on subsequent pregnancy…

other 2026
Archives of gynecology and obstetrics ·doi:10.1007/s00404-026-08490-4

PURPOSE: The magnetic resonance imaging (MRI)-based classification of adenomyosis subtypes helps predict reproductive and obstetric outcomes; however, background factors associated with use of assisted reproductive technology (ART) and live…

article 2023
Gynecology and minimally invasive therapy ·doi:10.4103/gmit.gmit_45_22

OBJECTIVES: The objective of this study was to observe the influence of laparoscopic adenomyomectomy on perinatal outcomes. MATERIALS AND METHODS: The retrospective cohort study included 43 pregnant cases with adenomyosis who did not under…

article 2020
The Tohoku journal of experimental medicine ·doi:10.1620/tjem.251.231

As the number of women who postpone their first pregnancy until their late 30s or early 40s is increasing, adenomyosis is more frequently encountered by obstetricians. Some studies have reported on the relationship between adenomyosis and p…

2009
BMJ case reports ·doi:10.1136/bcr.09.2008.0974

Splenic marginal zone lymphoma (SMZL) is a rare malignant lymphoma involving marginal zone B cells, accounting for only 1% of non-Hodgkin lymphomas. No previous reports have documented SMZL accompanied by massive bloody pleural effusion. He…